-+ 0.00%
-+ 0.00%
-+ 0.00%

TAIHO ONCOLOGY: TO SUBMIT NDA TO U.S. FDA SEEKING APPROVAL OF AZACITIDINE & CEDAZURIDINE AS ORAL TREATMENT REGIMEN FOR ADULTS WITH MDS OR CMML

路透·09/30/2026 20:15:12

請登錄查看新聞詳情